510(k) K233454
K233454 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Operations for the device "ONLINE TDM Methotrexate". The FDA issued a decision of Substantially Equivalent on Feb 20, 2024. The device falls under product code LAO (Enzyme Immunoassay, Methotrexate), a Class U device. Roche Diagnostics Operations has 6 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 20, 2024
- Date Received
- Oct 20, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Methotrexate
- Device Class
- Class U
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Roche Diagnostics Operations? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.